For the quarter ending 2026-03-31, SOLV had -$318M decrease in cash & cash equivalents over the period. -$273M in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 13 | 63 | 1,266 | 90 |
| Depreciation and amortization | 135 | 117 | 121 | 122 |
| Pension and postretirement benefits | 14 | 13 | 17 | 17 |
| Stock-based compensation expense | 51 | 37 | 41 | 34 |
| Gain on sale of business | - | 31 | 1,518 | - |
| Transaction costs | - | -25 | -86 | - |
| Deferred income taxes | -41 | -73 | 130 | -33 |
| Accounts receivable | 34 | 2 | -51 | 21 |
| Due from related parties | -28 | -7 | -33 | 1 |
| Inventories | 32 | 5 | 57 | 45 |
| Accounts payable | 23 | 30 | 51 | 14 |
| Due to related parties | -100 | -29 | 24 | 0 |
| Accrued compensation | -151 | 52 | 38 | 48 |
| All other operating activities net | -94 | -59 | -35 | -56 |
| Net cash provided by (used in) operating activities | -189 | 95 | 76 | 169 |
| Purchases of property, plant and equipment | 84 | 63 | 97 | 110 |
| Acquisitions, net of cash acquired | - | 696 | - | - |
| Proceeds from sale of business | - | 20 | 3,870 | - |
| Other net | -7 | 6 | 7 | 0 |
| Net cash used in investing activities | -77 | -745 | 3,766 | -110 |
| Repayment of debt | 0 | 100 | 2,770 | 100 |
| Proceeds from debt, net of issuance costs | 46 | 0 | 0 | 0 |
| Net transfers from (to) 3m | -2 | 12 | -9 | -1 |
| Purchases of treasury stock | 67 | - | - | - |
| Other net | -31 | -3 | 68 | -11 |
| Net cash used in financing activities | -50 | -115 | -2,693 | -110 |
| Effect of exchange rate changes on cash and cash equivalents | -2 | 1 | -1 | 6 |
| Net increase (decrease) in cash and cash equivalents | -318 | -764 | 1,148 | -45 |
| Cash and cash equivalents at beginning of period | 878 | 1,642 | 492 | 534 |
| Less cash and cash equivalents held for sale | 3 | - | - | -3 |
| Cash and cash equivalents at end of period | 561 | 878 | 1,642 | 492 |
Solventum Corp (SOLV)
Solventum Corp (SOLV)